Silence Therapeutics (SLN) Net Margin (2024 - 2026)
Silence Therapeutics (SLN) posted Net Margin of -3544.31% for the quarter ended Mar 31, 2026, up 16547.24 percentage points from -20091.55% a year earlier and up 31073.33 percentage points from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Net Margin (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics' Net Margin came in at -15851.88%, down 15747.14 percentage points from the prior year.
- Annual Net Margin shows a five-year change of -15258.70 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Silence Therapeutics' Net Margin was -104.74% in the year ended Dec 31, 2024 (+65.10 pp), -169.84% in the year ended Dec 31, 2023 (+61.62 pp), -231.46% in the year ended Dec 31, 2022 (+85.90 pp) and -317.36% in the year ended Dec 31, 2021 (+275.82 pp).
- The figure for the quarter ended Mar 31, 2026 stands as the highest quarterly Net Margin since the quarter ended Dec 31, 2024.
- On a year-over-year basis, Net Margin increased in 1 of the last five quarters, with an average year-over-year change of -11749.29 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -34617.65% (quarter ended Dec 31, 2025), -13181.13% (quarter ended Sep 30, 2025) and -12211.61% (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | Silence Therapeutics | 927.96 Mn | 855.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -3,544.31% |
| Dec 31, 2025 | -34,617.65% |
| Sep 30, 2025 | -13,181.13% |
| Jun 30, 2025 | -12,211.61% |
| Mar 31, 2025 | -20,091.55% |
| Dec 31, 2024 | 48.61% |
| Sep 30, 2024 | -2,372.76% |
| Jun 30, 2024 | -2,469.38% |
| Mar 31, 2024 | -14.73% |
API Access
Silence Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();